{"pre_text": ["rights each holder of a share of outstanding common stock also holds one share purchase right ( a \"right\" ) for each share of common stock .", "each right entitles the holder to purchase from the company one half of one-hundredth of a share of series a junior participating preferred stock , $ 0.01 par value ( the \"junior preferred shares\" ) , of the company at a price of $ 135 per one half of one-hundredth of a junior preferred share ( the \"purchase price\" ) .", "the rights are not exercisable until the earlier of acquisition by a person or group of 15% ( 15 % ) or more of the outstanding common stock ( an \"acquiring person\" ) or the announcement of an intention to make or commencement of a tender offer or exchange offer , the consummation of which would result in the beneficial ownership by a person or group of 15% ( 15 % ) or more of the outstanding common stock .", "in the event that any person or group becomes an acquiring person , each holder of a right other than the acquiring person will thereafter have the right to receive upon exercise that number of shares of common stock having a market value of two times the purchase price and , in the event that the company is acquired in a business combination transaction or 50% ( 50 % ) or more of its assets are sold , each holder of a right will thereafter have the right to receive upon exercise that number of shares of common stock of the acquiring company which at the time of the transaction will have a market value of two times the purchase price .", "under certain specified circumstances , the board of directors of the company may cause the rights ( other than rights owned by such person or group ) to be exchanged , in whole or in part , for common stock or junior preferred shares , at an exchange rate of one share of common stock per right or one half of one-hundredth of a junior preferred share per right .", "at any time prior to the acquisition by a person or group of beneficial ownership of 15% ( 15 % ) or more of the outstanding common stock , the board of directors of the company may redeem the rights in whole at a price of $ 0.01 per right .", "common stock reserved for future issuance at december 31 , 2003 , the company has reserved shares of common stock for future issuance under all equity compensation plans as follows ( shares in thousands ) : p .", "significant revenue arrangements the company has formed strategic collaborations with major pharmaceutical companies in the areas of drug discovery , development , and commercialization .", "research and development agreements provide the company with financial support and other valuable resources for research programs and development of clinical drug candidates , product development and marketing and sales of products .", "collaborative research and development agreements in the company's collaborative research , development and commercialization programs the company seeks to discover , develop and commercialize major pharmaceutical products in conjunction with and supported by the company's collaborators .", "collaborative research and development arrangements provide research funding over an initial contract period with renewal and termination options that vary by agreement .", "the agreements also include milestone payments based on the achievement or the occurrence of a designated event .", "the agreements may also contain development reimbursement provisions , royalty rights or profit sharing rights and manufacturing options .", "the terms of each agreement vary .", "the company has entered into significant research and development collaborations with large pharmaceutical companies .", "p .", "significant revenue arrangements novartis in may 2000 , the company and novartis pharma ag ( \"novartis\" ) entered into an agreement to collaborate on the discovery , development and commercialization of small molecule drugs directed at targets in the kinase protein family .", "under the agreement , novartis agreed to pay the company an up-front payment of $ 15000000 made upon signing of the agreement , up to $ 200000000 in product research funding over six ."], "post_text": ["."], "table": [["common stock under stock and option plans", "21829"], ["common stock under the vertex purchase plan", "249"], ["common stock under the vertex 401 ( k ) plan", "125"], ["total", "22203"]], "table_ori": [["Common stock under stock and option plans", "21,829"], ["Common stock under the Vertex Purchase Plan", "249"], ["Common stock under the Vertex 401(k) Plan", "125"], ["Total", "22,203"]]}

Question: what was the percentage change in the common stock and option
Evidence:
table_3: common stock under stock and option plans the total of 21829 is 22203 ;
Program: subtract(22203, 21829), divide(#0, 21829)
Answer:
str_answer: 1.7%
exe_answer: 0.01713